سعر هايجي ريكسال 120 مجم 30 كبسولة 2024

Hygirexal orlistat 120 mg capsules, pack of 30 (3 strips x 10), marketed in Egypt by Debeiky > Hygint Pharmaceuticals; listed for weight loss.

• Obesity management including weight loss and weight maintenance with a reduced-calorie diet, and to reduce the risk of weight regain after prior weight loss, in patients with BMI >=30 kg/m2 or >=27 kg/m2 with other risk factors (e.g. hypertension, diabetes, dyslipidaemia).Population: Adults; adolescents 12-16 years studiedDailyMed (U.S. National Library of Medicine)

• Most common: oily spotting, flatus with discharge, faecal urgency, fatty/oily stool, oily evacuation, increased defecation and faecal incontinence.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Post-marketing: hepatitis and hepatic failure, hypersensitivity reactions, leukocytoclastic vasculitis, acute oxalate nephropathy, pancreatitis, lower gastrointestinal bleeding.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Pregnancy.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Chronic malabsorption syndrome.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Cholestasis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Reduces absorption of some fat-soluble vitamins and beta-carotene: take a multivitamin with fat-soluble vitamins at least 2 hours before or after the dose (e.g. at bedtime).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Rare cases of severe liver injury, including hepatocellular necrosis and acute hepatic failure, have been reported; stop and check liver tests if symptoms of hepatic dysfunction occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Increased urinary oxalate with oxalate nephrolithiasis and oxalate nephropathy with renal failure has been reported; monitor renal function in patients at risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• CiclosporinReduced ciclosporin plasma levels; do not co-administer simultaneously, give ciclosporin 3 hours after orlistat and monitor levels more often.DailyMed (U.S. National Library of Medicine)
• LevothyroxineHypothyroidism reported; separate administration by at least 4 hours and monitor thyroid function.DailyMed (U.S. National Library of Medicine)
• Fat-soluble vitamin supplements (beta-carotene, vitamin E)Absorption reduced; take supplements at least 2 hours apart.DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm; no embryotoxicity or teratogenicity was seen in animal studies.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• It is not known whether orlistat is present in human milk; use caution in nursing women.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Orlistat: Reversible inhibitor of gastric and pancreatic lipases; reduces hydrolysis and absorption of dietary triglycerides.